OLD National Bancorp IN Buys 264 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

OLD National Bancorp IN raised its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 22.0% in the 4th quarter, HoldingsChannel reports. The firm owned 1,462 shares of the medical instruments supplier’s stock after purchasing an additional 264 shares during the quarter. OLD National Bancorp IN’s holdings in ICU Medical were worth $227,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the business. KBC Group NV raised its position in ICU Medical by 2,498.0% in the 4th quarter. KBC Group NV now owns 17,303 shares of the medical instruments supplier’s stock valued at $2,685,000 after purchasing an additional 16,637 shares during the last quarter. Inspire Investing LLC raised its position in ICU Medical by 13.2% in the 4th quarter. Inspire Investing LLC now owns 2,601 shares of the medical instruments supplier’s stock valued at $404,000 after purchasing an additional 303 shares during the last quarter. Diversified Trust Co raised its position in ICU Medical by 32.3% in the 4th quarter. Diversified Trust Co now owns 3,301 shares of the medical instruments supplier’s stock valued at $512,000 after purchasing an additional 805 shares during the last quarter. Principal Financial Group Inc. raised its position in ICU Medical by 24.6% in the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock valued at $23,130,000 after purchasing an additional 25,031 shares during the last quarter. Finally, Franklin Resources Inc. raised its position in ICU Medical by 99.3% in the 3rd quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier’s stock valued at $2,111,000 after purchasing an additional 5,834 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Insider Buying and Selling

In related news, Director David C. Greenberg sold 972 shares of ICU Medical stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the completion of the sale, the director now directly owns 5,037 shares of the company’s stock, valued at $796,400.07. The trade was a 16.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 17,737 shares of company stock valued at $2,879,752 over the last three months. Company insiders own 6.70% of the company’s stock.

ICU Medical Stock Down 0.9 %

Shares of ICU Medical stock opened at $164.36 on Monday. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 12 month low of $86.80 and a 12 month high of $196.26. The business has a fifty day simple moving average of $160.98 and a 200 day simple moving average of $162.52. The stock has a market cap of $4.02 billion, a PE ratio of -35.96 and a beta of 0.63.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ICUI. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. KeyCorp lifted their target price on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price for the company in a research note on Wednesday, December 11th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, ICU Medical currently has a consensus rating of “Moderate Buy” and an average price target of $199.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.